C8c-C15 monoseco-analogues of the phenanthroquinolizidine alkaloids julandine and cryptopleurine exhibiting potent anti-angiogenic properties

Bioorg Med Chem Lett. 2006 Jan 1;16(1):181-5. doi: 10.1016/j.bmcl.2005.09.032. Epub 2005 Oct 19.

Abstract

Four enantiomerically pure monoseco-analogues, 5, 7, 9, and 11, of the phenanthroquinolizidine alkaloid julandine (1) and four of congener cryptopleurine (2), viz. compounds 6, 8, 10, and 12, have been prepared and subjected to preliminary biological evaluation. These analogues show dramatically reduced cytotoxicity compared with the parent system 2 but they are, nevertheless, potent anti-angiogenic agents.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaloids / chemistry*
  • Alkaloids / pharmacology
  • Angiogenesis Inhibitors / pharmacology
  • Animals
  • Aorta / drug effects
  • Cell Line, Tumor
  • Drug Screening Assays, Antitumor / methods
  • Humans
  • Inhibitory Concentration 50
  • Mice
  • Models, Chemical
  • Phenanthrolines / chemistry*
  • Phenanthrolines / pharmacology
  • Quinolizines / chemistry*
  • Quinolizines / pharmacology
  • Rats
  • Stereoisomerism
  • Stilbenes / pharmacology

Substances

  • Alkaloids
  • Angiogenesis Inhibitors
  • Phenanthrolines
  • Quinolizines
  • Stilbenes
  • julandine
  • cryptopleurine
  • fosbretabulin